Case Report: QT Prolongation and Abortive Sudden Death Observed in an 85-Year-Old Female Patient With Advanced Lung Cancer Treated With Tyrosine Kinase Inhibitor Osimertinib
Cardiac arrest occurred in an 85-year-old female administered osimertinib for advanced lung cancer expressing epidermal growth factor receptor (EGFR) mutations. Electrocardiogram (ECG) recorded at recurrence of spontaneous circulation showed sinus rhythm associated with mild QT prolongation (QTc = 4...
Main Authors: | Moë Kondo, Megumi Kisanuki, Yosuke Kokawa, Seiichiro Gohara, Osamu Kawano, Shuntaro Kagiyama, Toru Maruyama, Keita Odashiro, Yoshihiko Maehara |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.655808/full |
Similar Items
-
QT Prolongation in Cancer Patients
by: Peter Kim, et al.
Published: (2021-02-01) -
Osimertinib-Induced Cardiotoxicity
by: Kartik Anand, MD, et al.
Published: (2019-12-01) -
QT/QTc safety and efficacy evaluation of teneligliptin in Indian type 2 diabetes mellitus patients: the “thorough QT/QTc” study (Q-SET study)
by: Erande S, et al.
Published: (2019-06-01) -
Association between C-reactive protein, corrected QT interval and presence of QT prolongation in hypertensive patients
by: Kai-Ting Chang, et al.
Published: (2014-06-01) -
Methods of Assessment and Clinical Relevance of QT Dynamics
by: Beata Sredniawa, et al.
Published: (2005-07-01)